Profit before tax jumped 20.11% to Rs 14.09 crore in Q3 FY25, compared to Rs 11.73 crore posted in Q3 FY24.
EBITDA was at Rs 11.34 crore in the third quarter of FY25, down 6.66% as against Rs 12.15 crore posted in Q3 FY24.
EBIDTA margin was at 24.47% in Q3 FY25, compared to 30.33% posted in Q3 FY24.
On nine-month basis, the company’s net profit jumped 82.08% to Rs 29.37 crore on a 17.41% rise in total income to Rs 127.03 crore posted in 9M FY25 over 9M FY24.
Aditya Kumar Halwasiya, chairman and MD, said, “We are delighted to announce a good set of numbers for the quarter. We are expanding our market presence and keep bringing new high-quality products to the market. We are honored to receive continuous orders from our customers in India and beyond.
It is a testament to our consistent quality, reliability, and commitment to supporting global health initiatives. Our new manufacturing facility at Palava near Mumbai is shaping up well and should be operational by the end of the current calendar year.”
Meanwhile, the company’s board has approved the appointment of Aditya Kumar Halwasiya as managing director and chairman of the company.
Cupid engaged in the business of dealing, marketing, and manufacturing rubber contraceptives and allied prophylactic products.
Shares of Cupid tumbled 5.60% to close at Rs 69.28 on Friday, 14 February 2025
Cupid standalone net profit rises 24.60% in the December 2024 quarter
15 - Feb - 2025 12:00 | 80 days ago
Net profit of Cupid rose 24.60% to Rs 11.04 crore in the quarter ended December 2024 as against Rs 8.86 crore during the previous quarter ended December 2023. Sales rose 15.73% to Rs 46.35 crore in the quarter ended December 2024 as against Rs 40.05 crore during the previous quarter ended December 2023.
Cupid standalone net profit rises 24.60% in the December 2024 quarter
15 - Feb - 2025 12:00 | 80 days ago
Net profit of Cupid rose 24.60% to Rs 11.04 crore in the quarter ended December 2024 as against Rs 8.86 crore during the previous quarter ended December 2023. Sales rose 15.73% to Rs 46.35 crore in the quarter ended December 2024 as against Rs 40.05 crore during the previous quarter ended December 2023.
Cupid prequalifies for upcoming South African Government Tender
24 - Jan - 2025 12:00 | 102 days ago
Cupid has received the prequalification for its Brown Caramel Female Condom Variant from the UNFPA.
This prequalification makes Cupid eligible to supply 100% of the Contract for Female Condoms in the upcoming RT75-2025 South African Government Tender which is for a duration of 5 years with bids closing on 31 January 2025.
Earlier, Cupid had been eligible to supply 75% of the Contract for Female Condoms in previous tenders which were for shorter durations of 3 years at a time.
Profit before tax jumped 20.11% to Rs 14.09 crore in Q3 FY25, compared to Rs 11.73 crore posted in Q3 FY24.
EBITDA was at Rs 11.34 crore in the third quarter of FY25, down 6.66% as against Rs 12.15 crore posted in Q3 FY24.
EBIDTA margin was at 24.47% in Q3 FY25, compared to 30.33% posted in Q3 FY24.
On nine-month basis, the company’s net profit jumped 82.08% to Rs 29.37 crore on a 17.41% rise in total income to Rs 127.03 crore posted in 9M FY25 over 9M FY24.
Aditya Kumar Halwasiya, chairman and MD, said, “We are delighted to announce a good set of numbers for the quarter. We are expanding our market presence and keep bringing new high-quality products to the market. We are honored to receive continuous orders from our customers in India and beyond.
It is a testament to our consistent quality, reliability, and commitment to supporting global health initiatives. Our new manufacturing facility at Palava near Mumbai is shaping up well and should be operational by the end of the current calendar year.”
Meanwhile, the company’s board has approved the appointment of Aditya Kumar Halwasiya as managing director and chairman of the company.
Cupid engaged in the business of dealing, marketing, and manufacturing rubber contraceptives and allied prophylactic products.
Shares of Cupid tumbled 5.60% to close at Rs 69.28 on Friday, 14 February 2025
Cupid standalone net profit rises 24.60% in the December 2024 quarter
15 - Feb - 2025 12:00 | 80 days ago
Net profit of Cupid rose 24.60% to Rs 11.04 crore in the quarter ended December 2024 as against Rs 8.86 crore during the previous quarter ended December 2023. Sales rose 15.73% to Rs 46.35 crore in the quarter ended December 2024 as against Rs 40.05 crore during the previous quarter ended December 2023.
Cupid prequalifies for upcoming South African Government Tender
24 - Jan - 2025 12:00 | 102 days ago
Cupid has received the prequalification for its Brown Caramel Female Condom Variant from the UNFPA.
This prequalification makes Cupid eligible to supply 100% of the Contract for Female Condoms in the upcoming RT75-2025 South African Government Tender which is for a duration of 5 years with bids closing on 31 January 2025.
Earlier, Cupid had been eligible to supply 75% of the Contract for Female Condoms in previous tenders which were for shorter durations of 3 years at a time.
Profit before tax jumped 20.11% to Rs 14.09 crore in Q3 FY25, compared to Rs 11.73 crore posted in Q3 FY24.
EBITDA was at Rs 11.34 crore in the third quarter of FY25, down 6.66% as against Rs 12.15 crore posted in Q3 FY24.
EBIDTA margin was at 24.47% in Q3 FY25, compared to 30.33% posted in Q3 FY24.
On nine-month basis, the company’s net profit jumped 82.08% to Rs 29.37 crore on a 17.41% rise in total income to Rs 127.03 crore posted in 9M FY25 over 9M FY24.
Aditya Kumar Halwasiya, chairman and MD, said, “We are delighted to announce a good set of numbers for the quarter. We are expanding our market presence and keep bringing new high-quality products to the market. We are honored to receive continuous orders from our customers in India and beyond.
It is a testament to our consistent quality, reliability, and commitment to supporting global health initiatives. Our new manufacturing facility at Palava near Mumbai is shaping up well and should be operational by the end of the current calendar year.”
Meanwhile, the company’s board has approved the appointment of Aditya Kumar Halwasiya as managing director and chairman of the company.
Cupid engaged in the business of dealing, marketing, and manufacturing rubber contraceptives and allied prophylactic products.
Shares of Cupid tumbled 5.60% to close at Rs 69.28 on Friday, 14 February 2025
Cupid standalone net profit rises 24.60% in the December 2024 quarter
15 - Feb - 2025 12:00 | 80 days ago
Net profit of Cupid rose 24.60% to Rs 11.04 crore in the quarter ended December 2024 as against Rs 8.86 crore during the previous quarter ended December 2023. Sales rose 15.73% to Rs 46.35 crore in the quarter ended December 2024 as against Rs 40.05 crore during the previous quarter ended December 2023.
Cupid standalone net profit rises 24.60% in the December 2024 quarter
15 - Feb - 2025 12:00 | 80 days ago
Net profit of Cupid rose 24.60% to Rs 11.04 crore in the quarter ended December 2024 as against Rs 8.86 crore during the previous quarter ended December 2023. Sales rose 15.73% to Rs 46.35 crore in the quarter ended December 2024 as against Rs 40.05 crore during the previous quarter ended December 2023.
Cupid prequalifies for upcoming South African Government Tender
24 - Jan - 2025 12:00 | 102 days ago
Cupid has received the prequalification for its Brown Caramel Female Condom Variant from the UNFPA.
This prequalification makes Cupid eligible to supply 100% of the Contract for Female Condoms in the upcoming RT75-2025 South African Government Tender which is for a duration of 5 years with bids closing on 31 January 2025.
Earlier, Cupid had been eligible to supply 75% of the Contract for Female Condoms in previous tenders which were for shorter durations of 3 years at a time.